Intercept Pharmaceuticals develops small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. read more
Intercept Pharmaceuticals CEO & Leadership Team Ratings
Mark Pruzanski and the Intercept Pharmaceuticals leadership team are scored a "B+" by 5 employees placing it in the Top 20% of companies sized 501-1,000 Employees on Comparably.
Mark Pruzanski Intercept Pharmaceuticals CEO Rating
Top 5% Compared to other companies of similar size in New YorkA+
85 / 100
Mark Pruzanski the CEO of Intercept Pharmaceuticals received an average score of 85 from Intercept Pharmaceuticals employees.Intercept Pharmaceuticals Manager Rating
Top 5% Compared to other companies of similar size in New YorkA+
100 / 100
Intercept Pharmaceuticals Executive Team Rating
N/A
0 / 100
×